AURO-RIVASTIGMINE

auro pharma inc🇨🇦 Health Canada

Approval Id: 02bfb880f86cf423
Drug Approval Canada Name: AURO-RIVASTIGMINE
Product Name: AURO-RIVASTIGMINE
Status: Dormant
Status Date: 2018-08-01
Original Market Date: 2016-04-12
Din: 02427575
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 12:04.00
Atc Original: N06DA03 RIVASTIGMINE
Atc Name: n 06 da 03
Aig Number: 0140521002
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

3 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

02bfb880f86cf423

Type

Standard